Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Dragoi

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Oncogenesis|August 16, 2016
FLASH protects ZEB1 from degradation and supports cancer cells' epithelial-to-mesenchymal transitionC F Abshire, J L Carroll, A-M Dragoi
Acta Endocrinologica (Bucharest, Romania : 2005)|October 8, 2020
THYROID HORMONES AS A THIRD LINE OF AUGMENTATION MEDICATION IN TREATMENT-RESISTANT DEPRESSIONS Trifu, A Popescu, A M Dragoi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Oncogenesis|August 16, 2016
FLASH protects ZEB1 from degradation and supports cancer cells' epithelial-to-mesenchymal transitionC F Abshire, J L Carroll, A-M Dragoi
Acta Endocrinologica (Bucharest, Romania : 2005)|October 8, 2020
THYROID HORMONES AS A THIRD LINE OF AUGMENTATION MEDICATION IN TREATMENT-RESISTANT DEPRESSIONS Trifu, A Popescu, A M Dragoi, et al.
Pageof 1